Research summary
Research summary
12/15/2025
Anthony Calabro, MA
In a large multicountry trial, researchers evaluated whether an integrase inhibitor–based regimen offers comparable or superior treatment outcomes to a boosted protease inhibitor regimen in adults with...
12/15/2025
Disease State Pillar
Disease State Pillar
12/09/2025
Miranda Manier, BA
Start fast, suppress durably, and think beyond the viral load: this primary care–focused guide covers diagnosis, same-day antiretroviral therapy, monitoring, opportunistic infection prevention, vaccines,...
12/09/2025
Conference Coverage
Conference Coverage
11/05/2025
Anthony Calabro, MA
In this multidisciplinary discussion, family medicine experts demonstrate how integrated team-based models, spanning primary care, behavioral health, pharmacy, and community services, can improve outcomes,...
11/05/2025
Conference Coverage
Conference Coverage
10/16/2025
Anthony Calabro, MA
Primary care teams face mounting pressure to succeed under value-based payment models, but fragmented data and inconsistent information sharing remain major obstacles. The American Academy of Family...
10/16/2025
Research Summary
Research Summary
09/24/2025
Kate Young
Stapokibart, a novel anti–IL-4Rα monoclonal antibody, significantly reduced nasal polyp size and congestion in patients with severe chronic rhinosinusitis with nasal polyps, with improvements evident as...
09/24/2025
Research Summary
Research Summary
09/23/2025
Anthony Calabro, MA
In patients with severe asthma who experience persistent exacerbations despite biologic therapy, azithromycin reduced both steroid- and antibiotic-requiring events and improved symptom control, according to...
09/23/2025
Research Summary
Research Summary
07/29/2025
Miranda Manier, BA
A palliative care training program for emergency clinicians did not reduce hospital admissions among older adults with serious illness, despite broad implementation.
07/29/2025
Conference Coverage
Conference Coverage
07/16/2025
Anthony Calabro, MA
Obstructive sleep apnea (OSA) is more prevalent and complex than often recognized—especially in women, older adults, and patients with comorbid conditions, according to Julianne Blythe, MPA, PA-C, RPSGT, a...
07/16/2025
Expert Q&A
Expert Q&A
05/20/2025
Anthony Calabro, MA
With three FDA-approved treatments now available, clinicians must learn to spot the early signs and understand the evolving science behind hidradenitis suppurativa (HS), a painful and stigmatizing disease....
05/20/2025
PUPC Conference Coverage
PUPC Conference Coverage
05/16/2025
Neal Skolnik, MD
In this interview, Neal Skolnik, MD, previews his Practical Updates in Primary Care 2025 presentation on evolving approaches to UTI management, including updated diagnostic guidance, emerging antibiotic...
05/16/2025